As of 3:59pm ET
| -0.016 / -3.23%|
The 1 analysts offering 12-month price forecasts for Sunesis Pharmaceuticals Inc have a median target of 2.50, with a high estimate of 2.50 and a low estimate of 2.50. The median estimate represents a +421.92% increase from the last price of 0.48.
The current consensus among 4 polled investment analysts is to Buy stock in Sunesis Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.